CliffBio
small molecule

ADASUVE

LOXAPINE

Loss of exclusivityOctober 2026latest FDA-listed patent expiry
CompanyNOVA PNEUMA INC

Drug detail

Brand nameADASUVE
Active ingredientLOXAPINE
Strength10MG
Dosage formPOWDER
RouteINHALATION
ModalitySmall molecule
FDA approvalDecember 2012
Marketing statusRX

Listed patents

PatentExpiresType
8387612October 2026product

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

ADASUVE patent cliff — loss of exclusivity October 2026 | CliffBio